These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 26817940)
1. Near real-time vaccine safety surveillance using electronic health records-a systematic review of the application of statistical methods. Leite A; Andrews NJ; Thomas SL Pharmacoepidemiol Drug Saf; 2016 Mar; 25(3):225-37. PubMed ID: 26817940 [TBL] [Abstract][Full Text] [Related]
2. Do delays in data availability limit the implementation of near real-time vaccine safety surveillance using the Clinical Practice Research Datalink? Leite A; Thomas SL; Andrews NJ Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):25-29. PubMed ID: 29193554 [TBL] [Abstract][Full Text] [Related]
3. Implementing near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD). Leite A; Thomas SL; Andrews NJ Vaccine; 2017 Dec; 35(49 Pt B):6885-6892. PubMed ID: 29056424 [TBL] [Abstract][Full Text] [Related]
5. Assessing recording delays in general practice records to inform near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD). Leite A; Andrews NJ; Thomas SL Pharmacoepidemiol Drug Saf; 2017 Apr; 26(4):437-445. PubMed ID: 28156036 [TBL] [Abstract][Full Text] [Related]
7. Safety of Vaccines Used for Routine Immunization in the United States. Maglione MA; Gidengil C; Das L; Raaen L; Smith A; Chari R; Newberry S; Hempel S; Shanman R; Perry T; Goetz MB Evid Rep Technol Assess (Full Rep); 2014 Jul; (215):1-740. PubMed ID: 30257278 [TBL] [Abstract][Full Text] [Related]
8. Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013-2014 and 2014-2015 seasons. Li R; Stewart B; McNeil MM; Duffy J; Nelson J; Kawai AT; Baxter R; Belongia EA; Weintraub E Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):928-34. PubMed ID: 27037540 [TBL] [Abstract][Full Text] [Related]
9. H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project. Lee GM; Greene SK; Weintraub ES; Baggs J; Kulldorff M; Fireman BH; Baxter R; Jacobsen SJ; Irving S; Daley MF; Yin R; Naleway A; Nordin JD; Li L; McCarthy N; Vellozzi C; Destefano F; Lieu TA; Am J Prev Med; 2011 Aug; 41(2):121-8. PubMed ID: 21767718 [TBL] [Abstract][Full Text] [Related]
11. Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. Daley MF; Yih WK; Glanz JM; Hambidge SJ; Narwaney KJ; Yin R; Li L; Nelson JC; Nordin JD; Klein NP; Jacobsen SJ; Weintraub E Vaccine; 2014 May; 32(25):3019-24. PubMed ID: 24699471 [TBL] [Abstract][Full Text] [Related]
12. Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013. Haber P; Moro PL; McNeil MM; Lewis P; Woo EJ; Hughes H; Shimabukuro TT Vaccine; 2014 Nov; 32(48):6499-504. PubMed ID: 25258101 [TBL] [Abstract][Full Text] [Related]
13. Challenges in the design and analysis of sequentially monitored postmarket safety surveillance evaluations using electronic observational health care data. Nelson JC; Cook AJ; Yu O; Dominguez C; Zhao S; Greene SK; Fireman BH; Jacobsen SJ; Weintraub ES; Jackson LA Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():62-71. PubMed ID: 22262594 [TBL] [Abstract][Full Text] [Related]
14. Near real-time vaccine safety surveillance with partially accrued data. Greene SK; Kulldorff M; Yin R; Yih WK; Lieu TA; Weintraub ES; Lee GM Pharmacoepidemiol Drug Saf; 2011 Jun; 20(6):583-90. PubMed ID: 21538670 [TBL] [Abstract][Full Text] [Related]
15. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511 [TBL] [Abstract][Full Text] [Related]
16. Allergic reactions to Japanese encephalitis vaccine. Plesner AM Immunol Allergy Clin North Am; 2003 Nov; 23(4):665-97. PubMed ID: 14753386 [TBL] [Abstract][Full Text] [Related]
17. Drug safety data mining with a tree-based scan statistic. Kulldorff M; Dashevsky I; Avery TR; Chan AK; Davis RL; Graham D; Platt R; Andrade SE; Boudreau D; Gunter MJ; Herrinton LJ; Pawloski PA; Raebel MA; Roblin D; Brown JS Pharmacoepidemiol Drug Saf; 2013 May; 22(5):517-23. PubMed ID: 23512870 [TBL] [Abstract][Full Text] [Related]
18. Real-time vaccine safety surveillance for the early detection of adverse events. Lieu TA; Kulldorff M; Davis RL; Lewis EM; Weintraub E; Yih K; Yin R; Brown JS; Platt R; Med Care; 2007 Oct; 45(10 Supl 2):S89-95. PubMed ID: 17909389 [TBL] [Abstract][Full Text] [Related]
19. The costs and effectiveness of large Phase III pre-licensure vaccine clinical trials. Black S Expert Rev Vaccines; 2015; 14(12):1543-8. PubMed ID: 26414015 [TBL] [Abstract][Full Text] [Related]
20. Monitoring the safety of high-dose, trivalent inactivated influenza vaccine in the vaccine adverse event reporting system (VAERS), 2011 - 2019. Moro PL; Woo EJ; Marquez P; Cano M Vaccine; 2020 Aug; 38(37):5923-5926. PubMed ID: 32709434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]